To: All persons or entities who purchased or otherwise acquired shares of
http://www.zlk.com/pslra/insys-therapeutics-inc-2
or contact
The complaint alleges that throughout the Class Period Defendants made false and/or misleading statements and/or failed to disclose that: (1) INSYS had overstated its 2015 net revenue; (2) INSYS had misstated its sales allowances for 2016; (3) accordingly, the Company lacked effective internal controls over financial reporting; and (4) as a result, INSYS public statements were materially false and misleading at all relevant times.
Take Action: if you suffered a loss in INSYS you have until
Levi & Korsinsky is a national firm with offices in
View source version on businesswire.com: http://www.businesswire.com/news/home/20170413006123/en/
Tel: 212-363-7500
Toll Free: 877-363-5972
Fax: 212-363-7171
www.zlk.com
Source:
Marathon Partners Calls for Change at OnDeck; Announces Intention to Vote Against Company’s Directors at Upcoming Annual Meeting
Baltia Air Lines Provides First Quarter 2017 Update in a Letter from Its Chairman & President
More Articles